Prevalence in LBBAP Recipients
There is no LBBAP-specific chronotropic incompetence (CI) prevalence in the published literature. Elderly LBBAP studies to date are built around procedural feasibility, safety, pacing parameters, and QRS or resynchronization endpoints rather than chronotropic response. Because left bundle branch area pacing is fundamentally a ventricular capture strategy, and chronotropic behavior is governed entirely on the atrial side of the system, chronotropic response is simply not what these cohorts report.
Prevalence must therefore be extrapolated from the broader paced and CRT-P populations, where estimates are heavily definition-dependent. Reported CI prevalence ranges from roughly 9% to 84% depending on the diagnostic threshold applied — failure to reach 80%, 85%, or 70% of age-predicted maximum heart rate, and absolute versus reserve-adjusted criteria all yield different figures. In pacemaker-clinic cohorts the prevalence trends high and tends to progress over time; one series reported an overall incidence near 58% and characterized CI as a progressive finding, which is a principal reason many implanters now default to rate-modulation-capable hardware even in patients who are chronotropically competent at implant.
In elderly CRT-P populations — arguably the closest proxy for a typical older conduction-system-pacing recipient, with median ages around 76 — CI is described as common on optimal medical therapy. A countervailing observation comes from small sinus node dysfunction cohorts, where most patients retained the ability to increase heart rate during exercise and only around 12% failed to reach 100 bpm, suggesting fixed CI in sinus node dysfunction may be less universal than a reflexive DDDR-for-all approach implies.
A reasonable working expectation for an elderly LBBAP cohort is therefore somewhere in the broad 20–60% range, contingent on the strictness of the definition and the prevalence of comorbidity and rate-limiting medication — while recognizing that the number is borrowed from adjacent populations rather than measured in LBBAP recipients directly.
Mechanism of a Blunted (5 bpm) Exercise Response
Framing the problem as sinus node dysfunction versus inadequate sensor drive can obscure that these two mechanisms usually sit in sequence along a single causal chain rather than competing as alternatives. In any device programmed to DDD with atrial tracking, the intrinsic sinus node response is the primary rate driver; the rate-response sensor exists only to substitute when that intrinsic response fails. The diagnostic task is therefore not to choose between the two but to locate where along that chain the rate signal is lost — and device interrogation answers this directly.
Interrogate the atrial channel during exercise. If the sensed P-wave rate rises appropriately but the ventricular rate lags, the problem is one of tracking or programming — upper tracking rate, AV delay, or mode — rather than chronotropic incompetence. If the intrinsic atrial rate itself remains essentially flat, rising only a few beats over baseline, that finding is sinus node dysfunction: the native node cannot accelerate, which is frequently the original pacing indication.
Once sinus node dysfunction is confirmed, a 5-bpm ceiling becomes, by definition, a sensor issue — because in the absence of an intrinsic response there is nothing else available to drive rate. The proximate causes are almost always programmatic or sensor-related: the device is programmed DDD rather than DDDR; rate response is enabled but conservatively configured (low upper sensor rate, high activity threshold, shallow reaction slope); or — very commonly during walking specifically — an accelerometer under-detects smooth, low-impact gait with a still upper body, and performs worse still during uphill walking, where metabolic demand rises but torso vibration does not. This is precisely the failure mode that motivated blended and minute-ventilation sensors; blended sensors restore chronotropic response more favorably than an accelerometer alone, and minute-ventilation sensor optimization has been studied specifically to recover exercise tolerance in older resynchronization populations.
The practical conclusion: in an already-implanted elderly patient, a persistent 5-bpm rise during moderate walking most often reflects inadequate sensor drive as the fixable proximate cause, layered upon underlying sinus node dysfunction as the reason a sensor is required at all. Attributing the blunted response to LBBAP itself would be a category error — the lead position is irrelevant to chronotropy.
To adjudicate cleanly, a real-time telemetered walk (or a formal chronotropic assessment such as the Chronotropic Assessment Exercise Protocol or a six-minute walk test) performed with the atrial channel visible is definitive: a flat intrinsic atrial rate directs management toward sensor reprogramming or a change of sensor type, whereas a rising atrial rate that the ventricle fails to follow directs attention back to tracking parameters. The Heart Rate Score derived from long-term device histograms offers a low-effort way to flag the problem at routine follow-up — a dominant single 10-bpm histogram bin is the characteristic fingerprint of a patient living at a single rate.
One confounder warrants explicit statement: rate-limiting drugs — beta-blockers, non-dihydropyridine calcium channel blockers, and several antiarrhythmic agents — can fully mimic or unmask this picture. Medication review therefore belongs in the workup before the sensor or the sinus node is concluded to be the culprit.